Exploring Immunotherapy in Cancer Treatment
In this special series, Medical News Bulletin delves into the transformative role of immunotherapy in cancer treatment. Discover the fundamentals of immunotherapy, its mechanisms, applications, and why it is considered a vital tool in modern oncology.
ANKTIVA Enhances BCG for Bladder Cancer
Posted: September 17, 2024
The FDA has granted approval for ANKTIVA, a drug designed to enhance the effects of Bacillus Calmette-Guerin (BCG), an established immunotherapy for bladder cancer. This innovative therapy aims to improve outcomes for patients with nonmuscle-invasive bladder cancer who have not responded to BCG alone, potentially reducing the necessity for bladder removal surgery.
Repurposing BCG: From TB Vaccine to Cancer Treatment
Posted: August 20, 2024
Bacillus Calmette-Guerin (BCG), originally developed as a vaccine for tuberculosis, has been repurposed to combat bladder cancer. This section explores the mechanisms behind BCG and its adaptation for treating this distinct disease.
Innovative Approaches to Melanoma Treatment
Posted: June 18, 2024
Researchers are investigating a novel treatment strategy for early-stage melanoma, the most severe form of skin cancer. By administering anti-cancer drugs directly to the tumor site, the aim is to minimize systemic side effects and improve recurrence rates of the disease.
Personalized Cancer Vaccines: A New Frontier
Posted: May 29, 2023
Recent advancements suggest that personalized cancer vaccines may soon become a reality. With stage IV melanoma having a five-year survival rate of just 16.2%, there is an urgent need for effective treatments. A recent study indicates that combining conventional therapy with a personalized anti-melanoma vaccine shows significant promise.
Understanding How Immunotherapy Works
Posted: May 5, 2021
Immunotherapy is a treatment that leverages the immune system to benefit patients. While the immune system serves as a defense against illness, it can sometimes be either underactive or overly aggressive. The concept of immunotherapy emerged to alleviate symptoms associated with immune-related diseases.
The Future of Immunotherapy for Glioblastoma
Posted: November 3, 2019
Researchers are testing new methods of administering immunotherapy to address challenges faced in treating glioblastoma, the most prevalent and aggressive form of brain cancer. The average survival duration for glioblastoma patients is approximately 14 months, highlighting the need for effective treatment strategies.
Challenges of Immunotherapy in Breast Cancer
Posted: February 27, 2019
A recent study examined why immunotherapy has not been as effective for breast cancer. Despite the advancements in immunotherapy and personalized medicine, breast cancer remains a challenging condition for these new therapies. Previous trials have indicated that immunotherapy may not yield the desired results in this context.
New Strategies in Cancer Immunotherapy
Posted: February 22, 2019
Traditionally, cancer treatments have focused on enhancing systemic immune activity. Researchers at Yale University are exploring more recent approaches to cancer immunotherapy that could lead to improved treatment efficacy. This evolution in cancer research emphasizes the importance of innovative strategies beyond conventional immune enhancement.